MTHFR
A plain-English explainer for parents who keep seeing “MTHFR” and want to understand why it matters.
What is MTHFR?
MTHFR is a gene that helps your body process folate (vitamin B9). That process supports methylation — a normal chemical “switching” system your body uses for many jobs.
- Supporting normal growth and development
- Managing inflammation signals
- Producing certain brain and nervous system chemicals
- Supporting multiple detox and repair pathways
Why do parents search for it in VaxCalc?
Many parents are trying to reduce vaccine-related risk — especially risk tied to ingredients, timing, and “stacking” multiple shots close together. When they hear that methylation affects how the body handles stress and inflammation, they naturally ask:
“If methylation works differently for my child, could that change how they respond?”
That's why MTHFR gets discussed — because kids' bodies don't all handle nutrients, toxins, medicines, or vaccines in exactly the same way.
Common variants
You may see names like C677T or A1298C. These are common genetic variants. Some variants can reduce how efficiently the MTHFR enzyme works. Many people have variants and never know it.
What’s known — and what isn’t
- Known: MTHFR affects folate processing and is connected to methylation pathways.
- Known: People vary in metabolism and inflammatory response.
- Not well-studied: Vaccine outcomes tracked and compared by MTHFR status at large scale.
- Reality: Vaccine schedules are not personalized using genetic information.
What VaxCalc can help you do (right now)
If you’re exploring MTHFR because you want clearer control over vaccine-related decisions, VaxCalc focuses on things you can actually evaluate:
Deeper MTHFR Research (Member Briefing)
This page is the public overview. Inside VaxCalc, members can access the full MTHFR research briefing — a structured planning guide that examines both the evidence and its limits.
- What vaccine trials measure — and what they do not measure — regarding genetic subgroups
- Explanation of active comparator trial design
- A layered risk model (genetics, ingredient load, timing, immune status, recovery capacity)
- Practical considerations about spacing between vaccines, how many are given in one visit, and cumulative ingredient exposure
- Question frameworks for clinical conversations
What is an “active comparator”?
In clinical research, many vaccine trials use what’s called an active comparator — meaning they compare one vaccine or an aluminum-containing formula against another exposure, rather than against an inert saline placebo. When one exposure is compared to another exposure, the study cannot measure outcomes relative to no exposure.
How this connects to VaxPlan
The member briefing moves beyond explanation into planning. It connects directly to VaxPlan (in active development), where members will be able to model visit timing and cumulative ingredient exposure inside a saved plan. The first release focuses on creating and saving a visit with cumulative ingredient totals.
If you are thinking carefully about spacing between vaccines, how many are given in one visit, and total ingredient load for your child, the member briefing is where structured planning begins.
Membership is required to view the full briefing inside VaxCalc.
Join to access the full MTHFR briefing →Note: This page is educational and focuses on research navigation. It does not provide medical advice, diagnosis, or treatment instructions.
Was this topic helpful?